Cargando…
DNA methylation and hormone receptor status in breast cancer
BACKGROUND: We examined whether differences in tumor DNA methylation were associated with more aggressive hormone receptor-negative breast cancer in an ethnically diverse group of patients in the Breast Cancer Care in Chicago (BCCC) study and using data from The Cancer Genome Atlas (TCGA). RESULTS:...
Autores principales: | Benevolenskaya, Elizaveta V., Islam, Abul B. M. M. K., Ahsan, Habibul, Kibriya, Muhammad G., Jasmine, Farzana, Wolff, Ben, Al-Alem, Umaima, Wiley, Elizabeth, Kajdacsy-Balla, Andre, Macias, Virgilia, Rauscher, Garth H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754852/ https://www.ncbi.nlm.nih.gov/pubmed/26884818 http://dx.doi.org/10.1186/s13148-016-0184-7 |
Ejemplares similares
-
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
por: Rauscher, Garth H., et al.
Publicado: (2015) -
Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer
por: Al-Alem, Umaima, et al.
Publicado: (2023) -
BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays
por: Mahmoud, Abeer M., et al.
Publicado: (2017) -
Prediction of Prostate Cancer Recurrence Using Quantitative Phase Imaging
por: Sridharan, Shamira, et al.
Publicado: (2015) -
Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma
por: Gurler, Hilal, et al.
Publicado: (2015)